Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

590 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis.
Halfon M, Taffé P, Bucher C, Haidar F, Huynh-do U, Mani LY, Schachtner T, Wehmeier C, Venetz JP, Pascual M, Fakhouri F, Golshayan D; Swiss Transplant Cohort Study. Halfon M, et al. Kidney Int Rep. 2024 Oct 15;10(1):75-86. doi: 10.1016/j.ekir.2024.10.008. eCollection 2025 Jan. Kidney Int Rep. 2024. PMID: 39810762 Free PMC article.
Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis.
Heidenreich S, Egger-Heidrich K, Halter JP, Jost L, Stölzel F, Perl M, Denk A, Edinger M, Herr W, Kröger N, Wolff D, Ayuk F, Fante MA. Heidenreich S, et al. Among authors: halter jp. Bone Marrow Transplant. 2025 Jan 14. doi: 10.1038/s41409-024-02507-9. Online ahead of print. Bone Marrow Transplant. 2025. PMID: 39809902
Distinct subtypes of post-transplant lymphoproliferative disorders: CHIP-like mutations in early lesions and substantial mutational differences between EBV-positive and EBV-negative diffuse large B-cell lymphomas.
Ivanova VS, Menter T, Cui N, Leary P, Zinner C, Halter JP, Stenner F, Dirnhofer S, Müller A, Tzankov A. Ivanova VS, et al. Among authors: halter jp. Br J Haematol. 2025 Jan 7. doi: 10.1111/bjh.19952. Online ahead of print. Br J Haematol. 2025. PMID: 39777628
BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia: A Swiss Transplant Cohort Study.
Hillenbrand CA, Akbari Bani D, Follonier O, Kaur A, Weissbach FH, Wernli M, Wilhelm M, Leuzinger K, Binet I, Bochud PY, Golshayan D, Hirzel C, Manuel O, Mueller NJ, Schaub S, Schachtner T, Van Delden C, Hirsch HH; Swiss Transplant Cohort Study. Hillenbrand CA, et al. Am J Transplant. 2024 Nov 22:S1600-6135(24)00707-X. doi: 10.1016/j.ajt.2024.11.019. Online ahead of print. Am J Transplant. 2024. PMID: 39580075 Free article.
Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.
Arber C, Baerlocher G, Chalandon Y, Daskalakis M, Duchosal M, Fehr M, Gerull S, Güngör T, Nair G, Pabst T, Passweg JR, Piccolruaz B, Renner C, Ruefer A, Schneidawind D, Stüssi G, Zeerleder S, Halter JP; Swiss Blood Stem Cell Transplant and Cellular Therapies (SBST) group. Arber C, et al. Among authors: halter jp. Swiss Med Wkly. 2024 Oct 3;154:3704. doi: 10.57187/s.3704. Swiss Med Wkly. 2024. PMID: 39463445 Free article. No abstract available.
590 results